DUBLIN, Ireland, Dec. 22, 2010 (GLOBE NEWSWIRE) — Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion’s patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
Following the feasibility studies, Novo [...] http://bit.ly/geHCoD
No comments:
Post a Comment